Straits Times Index
3,322.62 +14.72 (+0.45%) S&P 500
5,327.15 +20.14 (+0.38%) Dow
39,541.55 -129.49 (-0.33%) Nasdaq
16,959.25 +157.71 (+0.94%) Bitcoin USD
68,778.28 -873.58 (-1.25%) CMC Crypto 200
1,496.01 -6.65 (-0.44%)
Twist Bioscience Corporation (TWST)
| Previous close | 43.09 |
| Open | 43.06 |
| Bid | 41.75 x 600 |
| Ask | 42.46 x 400 |
| Day's range | 41.90 - 43.11 |
| 52-week range | 14.20 - 50.50 |
| Volume | |
| Avg. volume | 945,643 |
| Market cap | 2.451B |
| Beta (5Y monthly) | 1.63 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -3.36 |
| Earnings date | 02 Aug 2024 - 06 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 43.76 |
Business WireTwist Bioscience to Present at Upcoming Investor Conferences
SOUTH SAN FRANCISCO, Calif., May 23, 2024--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that its executives will present and participate in fireside chats at the following upcoming investor conferences:
ZacksWhat Makes Twist Bioscience (TWST) a Strong Momentum Stock: Buy Now?
Does Twist Bioscience (TWST) have what it takes to be a top stock pick for momentum investors? Let's find out.
Business WireTwist Bioscience Launches Multiplexed Gene Fragments to Enable High-throughput Screening Applications
SOUTH SAN FRANCISCO, Calif., May 13, 2024--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the launch of Twist Multiplexed Gene Fragments (MGFs), pools of directly synthesized double-stranded DNA (dsDNA) up to 500 base pairs in length with no limit on sequence number to enable high throughput screening applications.
